On Target: Pinpointing Prostate Cancer | Using MRI to guide the diagnosis

GE HealthCare Video

According to a study published on The Lancet, traditional prostate biopsy techniques have 48% accuracy at detecting clinically significant cancer, whereas MRI guided biopsy proved an accuracy of  up to 93%, and according to a study performed in Australia, without the use of MRI guided biopsy nearly one in five patients with prostate cancer would have undergone incorrect management of their disease. But Dr. Daniel Cornfeld, Mātai Clinical Lead & Head of Radiology at Te Whatu Ora Tairāwhiti (Gisborne Hospital), is leading a study, in collaboration with Dr. Michael Rice, Urologist at Auckland City Hospital, that focuses on the implementation of this procedure in Tairawhiti Gisborne with the goal of increasing the accuracy of the prostate cancer diagnosis pathway and advocating for guided biopsy as a national standard of care, to improve outcomes and equity in prostate cancer screening and diagnosis.